+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Veterinary Vaccines Market 2019-2028

  • ID: 5157444
  • Report
  • October 2020
  • Region: Global
  • 214 pages
  • Triton Market Research

FEATURED COMPANIES

  • Anicon Labor GmbH
  • Ceva Sante Animale
  • Hester Biosc
  • Phibro Animal Health Corp
  • Romvac Company Sa
  • Vaxxinova Gmbh-Germany

MARKET OUTLOOK

As per the publisher's report, the global veterinary vaccines market is anticipated to foster growth at a CAGR of 5.68% during the estimated years of 2019-2028.
The growing prevalence of zoonotic diseases and the rising prevalence of livestock diseases are key factors driving the veterinary vaccines market's growth. Additionally, the surge in the number of government agencies, along with the rise in the momentum of pet ownership, is opening several opportunities for the market's development during the projected phase. However, the adverse effects of post-vaccination and the shortage of skilled farmworkers obstruct the growth of the global market. The high cost of vaccinations is another factor that is challenging this market's progress in the future.

REGIONAL OUTLOOK

The global veterinary vaccines market covers North America, Asia-Pacific, Europe, Latin America, and the Middle East and Africa regions.
Globally, Asia-Pacific is estimated to become the fastest-growing market during the forecast years of 2019-2028. The developing countries in the region have observed significant expansion in the pet care industry. For instance, the Indian pet care industry has experienced growth due to a rise in the awareness relating to pet health and pet care products. Moreover, to suit the healthcare needs of adopted pets, vaccine production has increased commensurately in India. This further contributes to the development of vaccine technology, fueling the studied market's growth.

Further, there is a rise in the prevalence of Zoonosis in Japan. The increase in the occurrence of animal diseases results in the need to manage such conditions through the frequent use of vaccines. Therefore, the usage of vaccines to curb diseases is expected to foster the veterinary vaccines market's progress in the upcoming years.

COMPETITIVE OUTLOOK

The renowned companies involved in this market comprises Hester Biosciences Limited, Vaxxinova GmbH-Germany, Hygieia Biological Laboratories, Boehringer Ingelheim Animal Health GmbH, Zoetis, Elanco (Eli Lilly And Company), Phibro Animal Health Corp, HIPRA, Anicon Labor GmbH, Merck & Co, Virbac SA, Neogen Corporation, Romvac Company SA, and Ceva Sante Animale.
Neogen Corp is an international food safety corporation that offers test kits and relevant products to detect harmful substances present in food products. The company has a product line of over 100 drug detection test kits to detect abused and therapeutic drugs in animal treatment. It has its operation in numerous countries, including Mexico, Brazil, India, China, and Canada. The firm's headquarters are located in Michigan, the United States.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Anicon Labor GmbH
  • Ceva Sante Animale
  • Hester Biosc
  • Phibro Animal Health Corp
  • Romvac Company Sa
  • Vaxxinova Gmbh-Germany
1. Global Veterinary Vaccines Market - Summary

2. Industry Outlook
2.1. Market Definition
2.2. Porter's Five Forces Model
2.2.1. Threat of New Entrants
2.2.2. Threat of Substitute Products
2.2.3. Bargaining Power of Buyers
2.2.4. Bargaining Power of Suppliers
2.2.5. Threat of Competitive Rivalry
2.3. Impact of COVID-19 on Veterinary Vaccines Market
2.4. Industry Components
2.5. Regulatory Framework
2.6. Market Attractiveness Index
2.7. Vendor Scorecard
2.8. Market Drivers
2.8.1. Growth in Prevalence of Zoonotic Diseases
2.8.2. Rise in Livestock Diseases
2.9. Market Restraints
2.9.1. Adverse Effects of Post-Vaccination
2.9.2. Shortage of Skilled Farmworkers
2.10. Market Opportunities
2.10.1. Increase in Number of Initiatives by Government Agencies
2.10.2. Growth in Momentum of Pet Ownership
2.11. Market Challenge
2.11.1. High Costs of Vaccinations

3. Global Veterinary Vaccines Market Outlook - by Vaccine Type
3.1. Livestock Vaccine
3.1.1. Porcine Vaccine
3.1.2. Bovine Vaccine
3.1.3. Poultry Vaccine
3.1.4. Aquaculture Vaccine
3.1.5. Other Livestock Vaccine
3.2. Companion Vaccine
3.2.1. Canine Vaccine
3.2.2. Feline Vaccine
3.2.3. Equine Vaccine

4. Global Veterinary Vaccines Market Outlook - by Technology
4.1. Live Attenuated Vaccine
4.2. Inactivated Vaccine
4.3. Recombinant Vaccine
4.4. Toxoid Vaccine
4.5. Other Technology

5. Global Veterinary Vaccines Market Outlook - by Disease Type
5.1. Canine Disease
5.2. Porcine Disease
5.3. Bovine Disease
5.4. Poultry Disease
5.5. Aquaculture Disease
5.6. Other Disease Type

6. Global Veterinary Vaccines Market - Regional Outlook
6.1. North America
6.1.1. Market by Vaccine Type
6.1.1.1. Market by Livestock Vaccine
6.1.1.2. Market by Companion Vaccine
6.1.2. Market by Technology
6.1.3. Market by Disease Type
6.1.4. Country Analysis
6.1.4.1. the United States
6.1.4.2. Canada
6.2. Europe
6.2.1. Market by Vaccine Type
6.2.1.1. Market by Livestock Vaccine
6.2.1.2. Market by Companion Vaccine
6.2.2. Market by Technology
6.2.3. Market by Disease Type
6.2.4. Country Analysis
6.2.4.1. the United Kingdom
6.2.4.2. France
6.2.4.3. Germany
6.2.4.4. Italy
6.2.4.5. Russia
6.2.4.6. Spain
6.2.4.7. Rest of Europe
6.3. Asia-Pacific
6.3.1. Market by Vaccine Type
6.3.1.1. Market by Livestock Vaccine
6.3.1.2. Market by Companion Vaccine
6.3.2. Market by Technology
6.3.3. Market by Disease Type
6.3.4. Country Analysis
6.3.4.1. China
6.3.4.2. Japan
6.3.4.3. India
6.3.4.4. Australia & New Zealand
6.3.4.5. South Korea
6.3.4.6. Asean Countries
6.3.4.7. Rest of Asia-Pacific
6.4. Latin America
6.4.1. Market by Vaccine Type
6.4.1.1. Market by Livestock Vaccine
6.4.1.2. Market by Companion Vaccine
6.4.2. Market by Technology
6.4.3. Market by Disease Type
6.4.4. Country Analysis
6.4.4.1. Brazil
6.4.4.2. Mexico
6.4.4.3. Argentina
6.4.4.4. Rest of Latin America
6.5. Middle East and Africa
6.5.1. Market by Vaccine Type
6.5.1.1. Market by Livestock Vaccine
6.5.1.2. Market by Companion Vaccine
6.5.2. Market by Technology
6.5.3. Market by Disease Type
6.5.4. Regional Analysis

7. Company Profiles
7.1. Boehringer Ingelheim Animal Health Gmbh
7.2. Ceva Sante Animale
7.3. Hygieia Biological Laboratories
7.4. Anicon Labor Gmbh
7.5. Phibro Animal Health Corp
7.6. Romvac Company Sa
7.7. Elanco (Eli Lilly and Company)
7.8. Vaxxinova Gmbh-Germany
7.9. Zoetis
7.10. Hester Biosciences Limited
7.11. Hipra
7.12. Virbac Sa
7.13. Merck & Co
7.14. Neogen Corporation

8. Research Methodology & Scope
8.1. Research Scope & Deliverables
8.1.1. Objectives of Study
8.1.2. Scope of Study
8.2. Sources of Data
8.2.1. Primary Data Sources
8.2.2. Secondary Data Sources
8.3. Research Methodology
8.3.1. Evaluation of Proposed Market
8.3.2. Identification of Data Sources
8.3.3. Assessment of Market Determinants
8.3.4. Data Collection
8.3.5. Data Validation & Analysis

List of Tables
Table 1: Global Veterinary Vaccines Market, by Region, 2019-2028 (In $ Million)
Table 2: Market Snapshot - Veterinary Vaccine
Table 3: Vendor Scorecard
Table 4: Global Veterinary Vaccines Market, by Vaccine Type, 2019-2028 (In $ Million)
Table 5: Global Livestock Vaccine Market, by Type, 2019-2028 (In $ Million)
Table 6: Commercially Available Porcine Vaccines
Table 7: Commercially Available Poultry Vaccines
Table 8: Global Companion Vaccine Market, by Type, 2019-2028 (In $ Million)
Table 9: Commercially Available Canine Vaccines
Table 10: Commercially Available Feline Vaccines
Table 11: Commercially Available Equine Vaccines
Table 12: Global Veterinary Vaccines Market, by Technology, 2019-2028 (In $ Million)
Table 13: Global Veterinary Vaccines Market, by Disease Type, 2019-2028 (In $ Million)
Table 14: Global Veterinary Vaccines Market, by Region, 2019-2028 (In $ Million)
Table 15: North America Veterinary Vaccines Market, by Vaccine Type, 2019-2028 (In $ Million)
Table 16: North America Livestock Vaccine Market, by Type, 2019-2028 (In $ Million)
Table 17: North America Companion Vaccine Market, by Type, 2019-2028 (In $ Million)
Table 18: North America Veterinary Vaccines Market, by Technology, 2019-2028 (In $ Million)
Table 19: North America Veterinary Vaccines Market, by Disease Type, 2019-2028 (In $ Million)
Table 20: North America Veterinary Vaccines Market, by Country, 2019-2028 (In $ Million)
Table 21: Europe Veterinary Vaccines Market, by Vaccine Type, 2019-2028 (In $ Million)
Table 22: Europe Livestock Vaccine Market, by Type, 2019-2028 (In $ Million)
Table 23: Europe Companion Vaccine Market, by Type, 2019-2028 (In $ Million)
Table 24: Europe Veterinary Vaccines Market, by Technology, 2019-2028 (In $ Million)
Table 25: Europe Veterinary Vaccines Market, by Disease Type, 2019-2028 (In $ Million)
Table 26: Europe Veterinary Vaccines, by Country, 2019-2028 (In $ Million)
Table 27: Asia-Pacific Veterinary Vaccines Market, by Vaccine Type, 2019-2028 (In $ Million)
Table 28: Asia-Pacific Livestock Vaccine Market, by Type, 2019-2028 (In $ Million)
Table 29: Asia-Pacific Companion Vaccine Market, by Type, 2019-2028 (In $ Million)
Table 30: Asia-Pacific Veterinary Vaccines Market, by Technology, 2019-2028 (In $ Million)
Table 31: Asia-Pacific Veterinary Vaccines Market, by Disease Type, 2019-2028 (In $ Million)
Table 32: Asia-Pacific Veterinary Vaccines Market, by Country, 2019-2028 (In $ Million)
Table 33: Latin America Veterinary Vaccines Market, by Vaccine Type, 2019-2028 (In $ Million)
Table 34: Latin America Livestock Vaccine Market, by Type, 2019-2028 (In $ Million)
Table 35: Latin America Companion Vaccine Market, by Type, 2019-2028 (In $ Million)
Table 36: Latin America Veterinary Vaccines Market, by Technology, 2019-2028 (In $ Million)
Table 37: Latin America Veterinary Vaccines Market, by Disease Type, 2019-2028 (In $ Million)
Table 38: Latin America Veterinary Vaccines Market, by Country, 2019-2028 (In $ Million)
Table 39: Middle East and Africa Veterinary Vaccines Market, by Vaccine Type, 2019-2028 (In $ Million)
Table 40: Middle East and Africa Livestock Vaccine Market, by Type, 2019-2028 (In $ Million)
Table 41: Middle East and Africa Companion Vaccine Market, by Type, 2019-2028 (In $ Million)
Table 42: Middle East and Africa Veterinary Vaccines Market, by Technology, 2019-2028 (In $ Million)
Table 43: Middle East and Africa Veterinary Vaccines Market, by Disease Type, 2019-2028 (In $ Million)
Table 44: Middle East and Africa Veterinary Vaccines Market, by Country, 2019-2028 (In $ Million)

List of Figures
Figure 1: Global Veterinary Vaccines Market 2019-2028 (In $ Million)
Figure 2: Global Veterinary Vaccines Market, by Livestock Vaccine, 2019-2028 (In $ Million)
Figure 3: Global Livestock Vaccine Market, by Porcine Vaccine, 2019-2028 (In $ Million)
Figure 4: Global Livestock Vaccine Market, by Bovine Vaccine, 2019-2028 (In $ Million)
Figure 5: Global Livestock Vaccine Market, by Poultry Vaccine, 2019-2028 (In $ Million)
Figure 6: Global Livestock Vaccine Market, by Aquaculture Vaccine, 2019-2028 (In $ Million)
Figure 7: Global Livestock Vaccine Market, by Other Livestock Vaccine, 2019-2028 (In $ Million)
Figure 8: Global Veterinary Vaccines Market, by Companion Vaccine, 2019-2028 (In $ Million)
Figure 9: Global Companion Vaccine Market, by Canine Vaccine, 2019-2028 (In $ Million)
Figure 10: Global Companion Vaccine Market, by Feline Vaccine, 2019-2028 (In $ Million)
Figure 11: Global Companion Vaccine Market, by Equine Vaccine, 2019-2028 (In $ Million)
Figure 12: Global Veterinary Vaccines Market, by Live Attenuated Vaccine, 2019-2028 (In $ Million)
Figure 13: Global Veterinary Vaccines Market, by Inactivated Vaccine, 2019-2028 (In $ Million)
Figure 14: Global Veterinary Vaccines Market, by Recombinant Vaccine, 2019-2028 (In $ Million)
Figure 15: Global Veterinary Vaccines Market, by Toxoid Vaccine, 2019-2028 (In $ Million)
Figure 16: Global Veterinary Vaccines Market, by Other Technology, 2019-2028 (In $ Million)
Figure 17: Global Veterinary Vaccines Market, by Canine Disease, 2019-2028 (In $ Million)
Figure 18: Global Veterinary Vaccines Market, by Porcine Disease, 2019-2028 (In $ Million)
Figure 19: Global Veterinary Vaccines Market, by Bovine Disease, 2019-2028 (In $ Million)
Figure 20: Global Veterinary Vaccines Market, by Poultry Disease, 2019-2028 (In $ Million)
Figure 21: Global Veterinary Vaccines Market, by Aquaculture Disease, 2019-2028 (In $ Million)
Figure 22: Global Veterinary Vaccines Market, by Other Disease Type, 2019-2028 (In $ Million)
Figure 23: the United States Veterinary Vaccines Market 2019-2028 (In $ Million)
Figure 24: Canada Veterinary Vaccines Market 2019-2028 (In $ Million)
Figure 25: the United Kingdom Veterinary Vaccines Market 2019-2028 (In $ Million)
Figure 26: France Veterinary Vaccines Market 2019-2028 (In $ Million)
Figure 27: Germany Veterinary Vaccines Market 2019-2028 (In $ Million)
Figure 28: Italy Veterinary Vaccines Market 2019-2028 (In $ Million)
Figure 29: Russia Veterinary Vaccines Market 2019-2028 (In $ Million)
Figure 30: Spain Veterinary Vaccines Market 2019-2028 (In $ Million)
Figure 31: Rest of Europe Veterinary Vaccines Market 2019-2028 (In $ Million)
Figure 32: China Veterinary Vaccines Market 2019-2028 (In $ Million)
Figure 33: Japan Veterinary Vaccines Market 2019-2028 (In $ Million)
Figure 34: India Veterinary Vaccines Market 2019-2028 (In $ Million)
Figure 35: Australia & New Zealand Veterinary Vaccines Market 2019-2028 (In $ Million)
Figure 36: South Korea Veterinary Vaccines Market 2019-2028 (In $ Million)
Figure 37: Asean Countries Veterinary Vaccines Market 2019-2028 (In $ Million)
Figure 38: Rest of Asia-Pacific Veterinary Vaccines Market 2019-2028 (In $ Million)
Figure 39: Brazil Veterinary Vaccines Market 2019-2028 (In $ Million)
Figure 40: Mexico Veterinary Vaccines Market 2019-2028 (In $ Million)
Figure 41: Argentina Veterinary Vaccines Market 2019-2028 (In $ Million)
Figure 42: Rest of Latin America Veterinary Vaccines Market 2019-2028 (In $ Million)
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Boehringer Ingelheim Animal Health GmbH
  • Ceva Sante Animale
  • Hygieia Biological Laboratories
  • Anicon Labor GmbH
  • Phibro Animal Health Corp
  • Romvac Company Sa
  • Elanco (Eli Lilly and Company)
  • Vaxxinova Gmbh-Germany
  • Zoetis
  • Hester Biosc
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll